Table 2 Notable AMR STs by location
Location | Total ESBL (%) | Total CP (%) | Notable clone/s | N | N ESBL (% of ESBL/site) | ESBL genes (N) | N CP (% of CP/site) | CP genes (N) |
|---|---|---|---|---|---|---|---|---|
Hong Kong | 5 (19%) | 0 | – | – | – | – | – | – |
Vietnam | 20 (25%) | 4 (5%) | * ST15 | 7 | 4 (20%) | CTX-M-15 (3) CTX-M-14 (2) | 2 (50%) | NDM-1 (1) |
Thailand | 2 (50%) | 0 | – | – | – | – | – | – |
Laos | 32 (53%) | 1 (2%) | * ST15 | 14 | 14 (44%) | CTX-M-15 (14) | 0 | – |
ST76-1LV | 4 | 4 (13%) | CTX-M-15 (4) | 0 | – | |||
Cambodia | 27 (64%) | 1 (2%) | ST20 | 5 | 5 (19%) | CTX-M-27 (3) CTX-M-14 (2) CTX-M-15 (1) | 0 | – |
* ST15 | 3 | 3 (11%) | CTX-M-15 (3) CTX-M-27 (1) | 0 | – | |||
ST36 | 3 | 3 (11%) | CTX-M-15 (2) | 0 | – | |||
* ST15 | 8 | 8 (33%) | CTX-M-15 (8) | 6 (67%) | NDM-1 (5) | |||
Nepal | 24 (75%) | 9 (28%) | ST4 | 5 | 5 (21%) | CTX-M-15 (5) | 0 | – |
ST11 | 3 | 3 (13%) | SFO-1 (3) | 3 (33%) | OXA-232 (3) | |||
India | 52 (61%) | 42 (49%) | ST231 | 17 | 13 (25%) | CTX-M-15 (13) | 13 (31%) | OXA-232 (13) |
ST14 | 16 | 7 (13%) | CTX-M-15 (7) | 11 (26%) | OXA-232 (10) | |||
* ST15 | 4 | 3 (6%) | CTX-M-15 (3) | 0 | – | |||
ST16 | 3 | 3 (6%) | CTX-M-15 (3) | 2 (5%) | NDM-1 (1) | |||
ST29 | 3 | 3 (6%) | CTX-M-15 (3) | 0 | – | |||
ST395 | 3 | 1 (25%) | CTX-M-15 (1) | 3 (7%) | OXA-232 (3) |